Delivery Order SPE2DB22D3016-SPE2DB24FAJT4
Award Date 1/18/24
Potential Completion Date 1/19/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $2,610.79 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical and medical products, specifically 4563455615 IPOL VIAL 5ML. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,094.49 for IPOL vials (5mL) on July 15, 2025, with completion expected by July 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $8,966.00 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide "IPOL VIAL 5ML" pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that enables Amerisourcebergen Drug Corp to deliver a comprehensive range of medications and medical supplies to support military treatment programs and...
- This $80,412.48 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,470,416 units of the pharmaceutical product IPOL VIAL 5ML. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a wide range of...
- This federal contract award is for the delivery of 4564737139 IPOL VIAL 5ML medical products to the Defense Logistics Agency (DLA). The $131,704.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a May 30, 2024 completion date and was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is a delivery order valued at $14,942.90 for the supply of 4,565,424,297 units of IPOL VIAL 5ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML pharmaceutical product, with a ceiling value of $1,544.12. This competitive award, issued on September 14, 2025, with an ultimate completion date of September 15, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,180.20, is for the delivery of IPOL VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price and is scheduled for completion by May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for IPOL vials (5mL) valued at $5,450.50 under a firm fixed price contract type. This non-set-aside award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a standard medical supply delivery to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense (DoD) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,134.70 fixed-price delivery order is for the supply of 4,564,359,523 units of IPOL VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA)...